Trade Summary

2 days ago, Ridloff Elena, serving as Dir at Kymera Therapeutics, Inc. (KYMR), sold 3,000 shares at $87.00 per share, for a total transaction value of $261,000.00.

This sale represents a 100.00% decrease in Ridloff Elena's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, May 11, 2026 and publicly disclosed via SEC Form 4 filing on Monday, May 11, 2026, meaning the disclosure happened on the same day as the trade.

Kymera Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.